SCHEMBL1389648

SCHEMBL1389648

COc1cc(-c2cc(OC)cc(C(C)(C)C)c2Op2oc3ccccc3c3ccccc3o2)c(Op2oc3ccccc3c3ccccc3o2)c(C(C)(C)C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
MAOA P21397 4/20 0.33
KDM4E B2RXH2 4/20 0.33
RAB9A P51151 3/20 0.33
ALDH1A1 P00352 3/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
LMNA P02545 3/20 0.33
MAPT P10636 3/20 0.33
NPC1 O15118 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
ALOX15 P16050 1/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32
TNFRSF1A P19438 2/20 0.32
HPGD P15428 2/20 0.32
HDAC8 Q9BY41 1/20 0.31
TDP1 Q9NUW8 2/20 0.31
MAPK1 P28482 1/20 0.31
MAOB P27338 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29851350 1.00 CA1 (0.36) CA1CA2MAOAKDM4ERAB9A
SCHEMBL29421878 1.00 CA1 (0.36) CA1CA2MAOAKDM4ERAB9A
SCHEMBL15356799 0.94 CA1 (0.33) CA1CA2MAOAKDM4ERAB9A
SCHEMBL13214919 0.93 CA1 (0.32) CA1CA2MAOAHDAC8
SCHEMBL14476831 0.93 CA1 (0.43) CA1CA2MAOAKDM4EALDH1A1
SCHEMBL14207292 0.90 CA1 (0.30) CA1CA2
SCHEMBL17805173 0.90 MAOA (0.32) CA1CA2MAOAKDM4EALDH1A1
SCHEMBL19754905 0.89
SCHEMBL13652729 0.89
SCHEMBL17277948 0.88 CA1 (0.32) CA1CA2MAOAKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 273 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3114105-B1 METHOD FOR PRODUCING ALDEHYDES FROM ALKANES AND SYNTHESIS GAS EVONIK DEGUSSA GMBH (DE) 2018-05-09 EP claimed
EP-3114105-A1 METHOD FOR PRODUCING ALDEHYDES FROM ALKANES AND SYNTHESIS GAS Evonik Degussa GmbH (DE) 2017-01-11 EP claimed
WO-2015132068-A1 METHOD FOR PRODUCING ALDEHYDES FROM ALKANES AND SYNTHESIS GAS EVONIK DEGUSSA GMBH (DE) 2015-09-11 WO claimed
US-9018420-B2 Use of supported ionic liquid phase (SILP) catalyst systems in the hydroformylation of olefin-containing mixtures to aldehyde mixtures with a high content of aldehydes unbranched in the 2 position EVONIK OXENO GMBH (DE) 2015-04-28 US claimed
US-20130289313-A1 USE OF SUPPORTED IONIC LIQUID PHASE (SILP) CATALYST SYSTEMS IN THE HYDROFORMYLATION OF OLEFIN-CONTAINING MIXTURES TO ALDEHYDE MIXTURES WITH A HIGH CONTENT OF ALDEHYDES UNBRANCHED IN THE 2 POSITION EVONIK OXENO GMBH (DE) 2013-10-31 US claimed
US-7863487-B2 Hydroformylation process with improved control over product isomers DOW TECHNOLOGY INVESTMENTS LLC 2011-01-04 US claimed
US-20100069680-A1 HYDROFORMYLATION PROCESS WITH IMPROVED CONTROL OVER PRODUCT ISOMERS DOW TECHNOLOGY INVESTMENTS LLC 2010-03-18 US claimed
WO-2008115740-A1 HYDROFORMYLATION PROCESS WITH IMPROVED CONTROL OVER PRODUCT ISOMERS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY LLC (US) 2008-09-25 WO claimed
EP-0590613-B1 Improved hydroformylation process UNION CARBIDE CHEM PLASTIC (US) 1997-01-08 EP claimed
EP-0590613-A2 Improved hydroformylation process UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1994-04-06 EP claimed
US-12595221-B1 Hydroformylation processes DOW TECHNOLOGY INVESTMENTS LLC (US) 2026-04-07 US disclosed
US-20250137091-A1 PROCESSES FOR RECOVERING RHODIUM FROM HYDROFORMYLATION PROCESSES DOW TECHNOLOGY INVESTMENTS LLC (US) 2025-05-01 US disclosed
US-12030899-B2 Pt-biphenyl-iodine complex and Pt-biphenyl-bromine complex EVONIK OXENO GMBH & CO. KG (DE) 2024-07-09 US disclosed
US-12030899-B2 Pt-biphenyl-iodine complex and Pt-biphenyl-bromine complex EVONIK OXENO GMBH & CO. KG (DE) 2024-07-09 US disclosed
EP-4392401-A1 METHOD FOR THE PREPARATION OF OMEGA-AMINO-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF Versalis S.p.A. (IT) 2024-07-03 EP disclosed
EP-0872469-A1 Process for producing aldehyde acids or salts thereof UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1998-10-21 EP disclosed
EP-0872483-A1 Process for producing epsilon caprolactones from penten-1-ols UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1998-10-21 EP disclosed
EP-0846098-A1 IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1998-06-10 EP disclosed
WO-1997039996-A1 PROCESSES FOR PRODUCING ALKENOLS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1997-10-30 WO disclosed
WO-1997020793-A1 PROCESSES USING MULTISTAGED REACTORS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1997-06-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069680-A1 HYDROFORMYLATION PROCESS WITH IMPROVED CONTROL OVER PRODUCT ISOMERS HMOX2, HAO2, NUDT1 CA1 1045/4885CA2 864/4885MAOA 3234/4885
US-20130289313-A1 USE OF SUPPORTED IONIC LIQUID PHASE (SILP) CATALYST SYSTEMS IN THE HYDROFORMYLATION OF OLEFIN-CONTAINING MIXTURES TO ALDEHYDE MIXTURES WITH A HIGH CONTENT OF ALDEHYDES UNBRANCHED IN THE 2 POSITION OR10J3, H1-0, HRH4 CA1 773/4885CA2 917/4885MAOA 2140/4885
US-12030899-B2 Pt-biphenyl-iodine complex and Pt-biphenyl-bromine complex TPO, BRI3BP, POF1B CA1 2486/4885CA2 4081/4885MAOA 1144/4885
US-20250137091-A1 PROCESSES FOR RECOVERING RHODIUM FROM HYDROFORMYLATION PROCESSES NUDT1, HIRA, HARS1 CA1 3218/4885CA2 2892/4885MAOA 2214/4885
US-12595221-B1 Hydroformylation processes HSF1, ADH1A, HAO2 CA1 246/4885CA2 306/4885MAOA 630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.